Normal Clinical Laboratory Ranges by Age and Sex, and Impact on Study Screening Outcomes in Rural Mali
M'Bouye Doucoure,Amatigue Zeguime,Amadou Niangaly,Merepen A Guindo,Justin Y A Doritchamou,Mahamadoun H Assadou,Abdoulaye Katile,Moussa B Kanoute,Sidiki Perou,Adama Ouattara,Sintry Sanogo,Boucary Ouologuem,Souleymane Traore,Bakary Dao,Drissa Dembele,Mamady Kone,Bourama Kamate,Kourane Sissoko,Seydou Sankare,Sadio Diarra,Amagana Dolo,Mahamadou S Sissoko,Jennifer C C Hume,David Cook,Sara A Healy,J Patrick Gorres,Boubacar Traoré,Jordyn Gamiel,Patrick E Duffy,Issaka Sagara,M’Bouye Doucoure,Merepen A. Guindo,Justin Y. A. Doritchamou,Mahamadoun H. Assadou,Moussa B. Kanoute,Mahamadou S. Sissoko,Jennifer C. C. Hume,Sara A. Healy,J. Patrick Gorres,Patrick E. Duffy
DOI: https://doi.org/10.4269/ajtmh.23-0719
2024-03-26
Abstract:The interpretation of a laboratory test result requires an appropriate reference range established in healthy subjects, and normal ranges may vary by factors such as geographic region, sex, and age. We examined hematological and clinical chemistry parameters in healthy residents at two rural vaccine trial sites: Bancoumana and Doneguebougou in Mali, West Africa. During screening of clinical studies in 2018 and 2019, peripheral blood samples from 1,192 apparently healthy individuals age 6 months to 82 years were analyzed at a laboratory accredited by the College of American Pathologists for a complete blood count, and creatinine and/or alanine aminotransferase levels. Based on manufacturers’ reference range values, which are currently used in Malian clinical laboratories, abnormal values were common in this healthy population. In fact, 30.4% of adult participants had abnormal neutrophil levels and 19.8% had abnormal hemoglobin levels. Differences by sex were observed in those who were older, but not in those younger than 10 years, for several parameters, including hemoglobin, platelet, and absolute neutrophil counts in hematology, and creatinine in biochemistry. The site-specific reference intervals we report can be used in malaria vaccine clinical trials and other interventional studies, as well as in routine clinical care, to identify abnormalities in hematological and biochemical parameters among healthy Malian trial participants.
public, environmental & occupational health,tropical medicine